These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39233208)

  • 1. Uncoupling the CRMP2-Ca
    Allen HN; Hestehave S; Duran P; Nelson TS; Khanna R
    J Pain; 2024 Dec; 25(12):104664. PubMed ID: 39233208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling the CRMP2-Ca
    Allen HN; Hestehave S; Duran P; Nelson TS; Khanna R
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptidomimetic modulator of the Ca
    Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
    Feldman P; Khanna R
    Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.
    Buchta WC; Moutal A; Hines B; Garcia-Keller C; Smith ACW; Kalivas P; Khanna R; Riegel AC
    Mol Neurobiol; 2020 Jan; 57(1):346-357. PubMed ID: 31359322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
    François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
    Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.
    Perez-Miller S; Gomez K; Khanna R
    ACS Pharmacol Transl Sci; 2024 Jul; 7(7):1916-1936. PubMed ID: 39022365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
    Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
    Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons.
    Cai S; Shan Z; Zhang Z; Moutal A; Khanna R
    Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
    Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
    Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV-encoded Ca
    Yu H; Shin SM; Xiang H; Chao D; Cai Y; Xu H; Khanna R; Pan B; Hogan QH
    Gene Ther; 2019 Aug; 26(7-8):308-323. PubMed ID: 31118475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
    Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R
    Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.
    Wilson SM; Brittain JM; Piekarz AD; Ballard CJ; Ripsch MS; Cummins TR; Hurley JH; Khanna M; Hammes NM; Samuels BC; White FA; Khanna R
    Channels (Austin); 2011; 5(5):449-56. PubMed ID: 21829088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRMP2-Neurofibromin Interface Drives NF1-related Pain.
    Moutal A; Sun L; Yang X; Li W; Cai S; Luo S; Khanna R
    Neuroscience; 2018 Jun; 381():79-90. PubMed ID: 29655575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.
    Chi XX; Schmutzler BS; Brittain JM; Wang Y; Hingtgen CM; Nicol GD; Khanna R
    J Cell Sci; 2009 Dec; 122(Pt 23):4351-62. PubMed ID: 19903690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological evidence for voltage-gated calcium channel 2 (Cav2) modulation of mechano- and thermosensitive spinal neuronal responses in a rat model of osteoarthritis.
    Rahman W; Patel R; Dickenson AH
    Neuroscience; 2015 Oct; 305():76-85. PubMed ID: 26247695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.
    Ju W; Li Q; Allette YM; Ripsch MS; White FA; Khanna R
    J Neurochem; 2013 Mar; 124(6):869-79. PubMed ID: 23106100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels.
    Shan Z; Cai S; Yu J; Zhang Z; Vallecillo TGM; Serafini MJ; Thomas AM; Pham NYN; Bellampalli SS; Moutal A; Zhou Y; Xu GB; Xu YM; Luo S; Patek M; Streicher JM; Gunatilaka AAL; Khanna R
    ACS Chem Neurosci; 2019 Jun; 10(6):2939-2955. PubMed ID: 30946560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
    Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.
    Brittain JM; Duarte DB; Wilson SM; Zhu W; Ballard C; Johnson PL; Liu N; Xiong W; Ripsch MS; Wang Y; Fehrenbacher JC; Fitz SD; Khanna M; Park CK; Schmutzler BS; Cheon BM; Due MR; Brustovetsky T; Ashpole NM; Hudmon A; Meroueh SO; Hingtgen CM; Brustovetsky N; Ji RR; Hurley JH; Jin X; Shekhar A; Xu XM; Oxford GS; Vasko MR; White FA; Khanna R
    Nat Med; 2011 Jun; 17(7):822-9. PubMed ID: 21642979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.